Berberine and its structural analogs have differing effects on functional profiles of individual gut microbiomes

References

• Wilson ID, Nicholson JK. Gut microbiome interactions with drug metabolism, efficacy, and toxicity. Transl Res. 2017;179:204–222. doi:https://doi.org/10.1016/j.trsl.2016.08.002.
   Google Scholar
• Guthrie L, Wolfson S, Kelly L. The human gut chemical landscape predicts microbe-mediated biotransformation of foods and drugs. eLife. 2019;8:e42866. doi:https://doi.org/10.7554/eLife.42866.
   Google Scholar
• Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature. 2018;555:623–628. doi:https://doi.org/10.1038/nature25979.
   Google Scholar
• Dutta D, Mishra S. L-Captopril and its derivatives as potential inhibitors of microbial enzyme DapE: a combined approach of drug repurposing and similarity screening. J Mol Grapj Model. 2018;84:82–89. doi:https://doi.org/10.1016/j.jmgm.2018.06.004.
   Google Scholar
• Kubinyi H. Chemical similarity and biological activities. J Braz Chem Soc. 2002;13:717–726. doi:https://doi.org/10.1590/S0103-50532002000600002.
   Google Scholar
• Wiggers HJ, Crusca E, ÉED S, Cheleski J, Torres NU, Navarro MVAS. Identification of anti-inflammatory and anti-hypertensive drugs as inhibitors of bacterial diguanylate cyclases. J Braz Chem Soc. 2018;29:297–309.
   Google Scholar
• Jiang X-W, Zhang Y, Zhu Y-L, Zhang H, Lu K, Li -F-F, Peng H-Y. Effects of berberine gelatin on recurrent aphthous stomatitis: a randomized, placebo-controlled, double-blind trial in a Chinese cohort. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;115:212–217. doi:https://doi.org/10.1016/j.oooo.2012.09.009.
   Google Scholar
• Li H-L, Han T, Liu R-H, Zhang C, Chen H-S, Zhang W-D. Alkaloids from corydalis saxicola and their anti-hepatitis b virus activity. Chem Biodivers. 2008;5:777–783. doi:https://doi.org/10.1002/cbdv.200890074.
   Google Scholar
• Yin J, Gao Z, Liu D, Liu Z, Ye J. Berberine improves glucose metabolism through induction of glycolysis. Am J Physiol-Endoc M. 2008;294:E148–E56.
   Google Scholar
• Yin J, Ye J, Jia W. Effects and mechanisms of berberine in diabetes treatment. Acta Pharmacol Sin B. 2012;2:327–334. doi:https://doi.org/10.1016/j.apsb.2012.06.003.
   Google Scholar
• Affuso F, Mercurio V, Fazio V, Fazio S. Cardiovascular and metabolic effects of berberine. World J Cardiol. 2010;2:71–77. doi:https://doi.org/10.4330/wjc.v2.i4.71.
   Google Scholar
• Guo -H-H, Feng C-L, Zhang W-X, Luo Z-G, Zhang H-J, Zhang -T-T, Ma C, Zhan Y, Li R, Wu S, et al. Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases. Nat Commun. 2019;10:1981. doi:https://doi.org/10.1038/s41467-019-09852-0.
   Google Scholar
• Lv X-Y, Li J, Zhang M, Wang C-M, Fan Z, Wang C-Y, Chen L. Enhancement of sodium caprate on intestine absorption and antidiabetic action of berberine. AAPS PharmSciTech. 2010;11:372–382. doi:https://doi.org/10.1208/s12249-010-9386-z.
   Google Scholar
• Cheng Z-F, Zhang Y-Q, Liu F-C. Berberine against gastrointestinal peptides elevation and mucous secretion in hyperthyroid diarrheic rats. Regul Pept. 2009;155:145–149. doi:https://doi.org/10.1016/j.regpep.2008.12.008.
   Google Scholar
• Kuo C-L, Chi C-W, Liu T-Y. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett. 2004;203:127–137. doi:https://doi.org/10.1016/j.canlet.2003.09.002.
   Google Scholar
• Lee C-H, Chen J-C, Hsiang C-Y, Wu S-L, Wu H-C, Ho T-Y. Berberine suppresses inflammatory agents-induced interleukin-1β and tumor necrosis factor-α productions via the inhibition of IκB degradation in human lung cells. Pharmacol Res. 2007;56:193–201. doi:https://doi.org/10.1016/j.phrs.2007.06.003.
   Google Scholar
• Wang H, Zhu C, Ying Y, Luo L, Huang D, Luo Z. Metformin and berberine, two versatile drugs in treatment of common metabolic diseases. Oncotarget. 2017;9:10135–10146. doi:https://doi.org/10.18632/oncotarget.20807.
   Google Scholar
• Mao L, Chen Q, Gong K, Xu X, Xie Y, Zhang W, Cao H, Hu T, Hong X, Zhan Y. Berberine decelerates glucose metabolism via suppression of mTOR-dependent HIF-1α protein synthesis in colon cancer cells. Oncol Rep. 2018;39:2436–2442. doi:https://doi.org/10.3892/or.2018.6318.
   Google Scholar
• Zhu L, Zhang D, Zhu H, Zhu J, Weng S, Dong L, Liu T, Hu Y, Shen X. Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe−/− mice. Atherosclerosis. 2018;268:117–126. doi:https://doi.org/10.1016/j.atherosclerosis.2017.11.023.
   Google Scholar
• Xie W, Gu D, Li J, Cui K, Zhang Y. Effects and action mechanisms of berberine and Rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J mice. PLoS One. 2011;6:e24520–e20. doi:https://doi.org/10.1371/journal.pone.0024520.
   Google Scholar
• Tian Y, Cai J, Gui W, Nichols RG, Koo I, Zhang J, Anitha M, Patterson AD. Berberine directly affects the gut microbiota to promote intestinal farnesoid X receptor activation. Drug Metab Dispos. 2019;47:86. doi:https://doi.org/10.1124/dmd.118.083691.
   Google Scholar
• Sun H, Wang N, Cang Z, Zhu C, Zhao L, Nie X, Cheng J, Xia F, Zhai H, Lu Y. Modulation of microbiota-gut-brain axis by berberine resulting in improved metabolic status in high-fat diet-fed rats. Obes Facts. 2016;9:365–378. doi:https://doi.org/10.1159/000449507.
   Google Scholar
• Zou K, Li Z, Zhang Y, Zhang H-Y, Li B, Zhu W-L, Shi J-Y, Jia Q. Li Y-m: advances in the study of berberine and its derivatives: a focus on anti-inflammatory and anti-tumor effects in the digestive system. Acta Pharmacol Sin. 2016;38:157. doi:https://doi.org/10.1038/aps.2016.125.
   Google Scholar
• Wang Y-X, Wang Y-P, Zhang H, Kong W-J, Li Y-H, Liu F, Gao R-M, Liu T, Jiang J-D, Song D-Q. Synthesis and biological evaluation of berberine analogues as novel up-regulators for both low-density-lipoprotein receptor and insulin receptor. Bioorg Med Chem Lett. 2009;19:6004–6008. doi:https://doi.org/10.1016/j.bmcl.2009.09.059.
   Google Scholar
• Roselli M, Cavalluzzi MM, Bruno C, Lovece A, Carocci A, Franchini C, Habtemariam S, Lentini G. Synthesis and evaluation of berberine derivatives and analogs as potential antiacetylcholinesterase and antioxidant agents. Phytochem Lett. 2016;18:150–156. doi:https://doi.org/10.1016/j.phytol.2016.10.005.
   Google Scholar
• Guaman Ortiz LM, Tillhon M, Parks M, Dutto I, Prosperi E, Savio M, Arcamone AG, Buzzetti F, Lombardi P, Scovassi AI. Multiple effects of berberine derivatives on colon cancer cells. Biomed Res Int. 2014;2014:12. doi:https://doi.org/10.1155/2014/924585.
   Google Scholar
• Ding Y, Ye X, Zhu J, Zhu X, Li X, Chen B. Structural modification of berberine alkaloid and their hypoglycemic activity. J Funct Foods. 2014;7:229–237. doi:https://doi.org/10.1016/j.jff.2014.02.007.
   Google Scholar
• Čerňáková M, Košťálová D. Antimicrobial activity of berberine—a constituent of Mahonia aquifolium. Folia Microbiol. 2002;47:375–378. doi:https://doi.org/10.1007/BF02818693.
   Google Scholar
• Iwasa K, Kamigauchi M, Ueki M, Taniguchi M. Antibacterial activity and structure-activity relationships of berberine analogs. Eur J Med Chem. 1996;31:469–478. doi:https://doi.org/10.1016/0223-5234(96)85167-1.
   Google Scholar
• Li L, Abou-Samra E, Ning Z, Zhang X, Mayne J, Wang J, Cheng K, Walker K, Stintzi A, Figeys D. An in vitro model maintaining taxon-specific functional activities of the gut microbiome. Nat Commun. 2019;10:4146. doi:https://doi.org/10.1038/s41467-019-12087-8.
   Google Scholar
• Mills RH, Vázquez-Baeza Y, Zhu Q, Jiang L, Gaffney J, Humphrey G, Smarr L, Knight R, Gonzalez DJ. Evaluating metagenomic prediction of the metaproteome in a 4.5-year study of a patient with Crohn’s disease. mSystems. 2019;4:e00337–18. doi:https://doi.org/10.1128/mSystems.00337-18.
   Google Scholar
• Zhang X, Figeys D. Perspective and guidelines for metaproteomics in microbiome studies. J Proteome Res. 2019;18:2370–2380. doi:https://doi.org/10.1021/acs.jproteome.9b00054.
   Google Scholar
• Li L, Ning Z, Zhang X, Mayne J, Cheng K, Stintzi A, Figeys D. RapidAIM: A culture- and metaproteomics-based rapid assay of individual microbiome responses to drugs. Microbiome. 2020;8:33. doi:https://doi.org/10.1186/s40168-020-00806-z.
   Google Scholar
• Liao B, Ning Z, Cheng K, Zhang X, Li L, Mayne J, Figeys D. iMetaLab 1.0: a web platform for metaproteomics data analysis. Bioinformatics. 2018;34:3954–3956. doi:https://doi.org/10.1093/bioinformatics/bty466.
   Google Scholar
• Vital M, Howe AC, Tiedje JM. Revealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic data. mBio. 2014;5:e00889–14. doi:https://doi.org/10.1128/mBio.00889-14.
   Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 1997;23:3–25. doi:https://doi.org/10.1016/S0169-409X(96)00423-1.
   Google Scholar
• Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A. 2013;110:9066. doi:https://doi.org/10.1073/pnas.1219451110.
   Google Scholar
• Anhê FF, Roy D, Pilon G, Dudonné S, Matamoros S, Varin TV, Garofalo C, Moine Q, Desjardins Y, Levy E, et al. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut. 2015;64:872. doi:https://doi.org/10.1136/gutjnl-2014-307142.
   Google Scholar
• Grander C, Adolph TE, Wieser V, Lowe P, Wrzosek L, Gyongyosi B, Ward DV, Grabherr F, Gerner RR, Pfister A, et al. Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease. Gut. 2018;67:891. doi:https://doi.org/10.1136/gutjnl-2016-313432.
   Google Scholar
• Smits SA, Leach J, Sonnenburg ED, Gonzalez CG, Lichtman JS, Reid G, Knight R, Manjurano A, Changalucha J, Elias JE, et al. Seasonal cycling in the gut microbiome of the Hadza hunter-gatherers of Tanzania. Science. 2017;357:802. doi:https://doi.org/10.1126/science.aan4834.
   Google Scholar
• Cani PD, de Vos WM. Next-generation beneficial microbes: the case of Akkermansia muciniphila. Front Microbiol. 2017;8:1765. doi:https://doi.org/10.3389/fmicb.2017.01765.
   Google Scholar
• Kupsch EM, Knepper B, Kuroki T, Heuer I, Meyer TF. Variable opacity (Opa) outer membrane proteins account for the cell tropisms displayed by Neisseria gonorrhoeae for human leukocytes and epithelial cells. Embo J. 1993;12:641–650. doi:https://doi.org/10.1002/j.1460-2075.1993.tb05697.x.
   Google Scholar
• Hauck CR, Meyer TF. ‘Small’ talk: opa proteins as mediators of Neisseria–host-cell communication. Curr Opin Microbiol. 2003;6:43–49. doi:https://doi.org/10.1016/S1369-5274(03)00004-3.
   Google Scholar
• Raivio TL. MicroReview: envelope stress responses and Gram-negative bacterial pathogenesis. Mol Microbiol. 2005;56:1119–1128. doi:https://doi.org/10.1111/j.1365-2958.2005.04625.x.
   Google Scholar
• Scott KP, Gratz SW, Sheridan PO, Flint HJ, Duncan SH. The influence of diet on the gut microbiota. Pharmacol Res. 2013;69:52–60. doi:https://doi.org/10.1016/j.phrs.2012.10.020.
   Google Scholar
• Majid HA, Emery PW, Whelan K. Faecal microbiota and short-chain fatty acids in patients receiving enteral nutrition with standard or fructo-oligosaccharides and fibre-enriched formulas. J Hum Nutr Diet. 2011;24:260–268. doi:https://doi.org/10.1111/j.1365-277X.2011.01154.x.
   Google Scholar
• Le Leu RK, Hu Y, Brown IL, Young GP. Effect of high amylose maize starches on colonic fermentation and apoptotic response to DNA-damage in the colon of rats. Nutr Metab (Lond). 2009;6:11. doi:https://doi.org/10.1186/1743-7075-6-11.
   Google Scholar
• Haenen D, Zhang J, Souza da Silva C, Bosch G, van der Meer IM, van Arkel J, van den Borne JJ, Perez GO, Smidt H, Kemp B, et al. A diet high in resistant starch modulates microbiota composition, SCFA concentrations, and gene expression in pig intestine. J Nutr. 2013;143:274–283. doi:https://doi.org/10.3945/jn.112.169672.
   Google Scholar
• Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 2008;27:104–119. doi:https://doi.org/10.1111/j.1365-2036.2007.03562.x.
   Google Scholar
• Chang PV, Hao L, Offermanns S, Medzhitov R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci U S A. 2014;111:2247–2252. doi:https://doi.org/10.1073/pnas.1322269111.
   Google Scholar
• Bjerrum JT, Wang Y, Hao F, Coskun M, Ludwig C, Gunther U, Nielsen OH. Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn’s disease and healthy individuals. Metabolomics. 2015;11:122–133. doi:https://doi.org/10.1007/s11306-014-0677-3.
   Google Scholar
• Turner N, Li J-Y, Gosby A, To SWC, Cheng Z, Miyoshi H, Taketo MM, Cooney GJ, Kraegen EW, James DE, et al. Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I. Diabetes. 2008;57:1414. doi:https://doi.org/10.2337/db07-1552.
   Google Scholar
• Li L, Zhang X, Ning Z, Mayne J, Moore JI, Butcher J, Chiang C-K, Mack D, Stintzi A, Figeys D. Evaluating in vitro culture medium of gut microbiome with orthogonal experimental design and a metaproteomics approach. J Proteome Res. 2018;17:154–163. doi:https://doi.org/10.1021/acs.jproteome.7b00461.
   Google Scholar
• Li J, Jia H, Cai X, Zhong H, Feng Q, Sunagawa S, Arumugam M, Kultima JR, Prifti E, Nielsen T, et al. An integrated catalog of reference genes in the human gut microbiome. Nat Biotech. 2014;32:834. doi:https://doi.org/10.1038/nbt.2942.
   Google Scholar
• Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteomics. 2014;13:2513–26. doi:https://doi.org/10.1074/mcp.M113.031591.
   Google Scholar
• Chen C, Grennan K, Badner J, Zhang D, Gershon E, Jin L, Liu C. Removing batch effects in analysis of expression microarray data: an evaluation of six batch adjustment methods. PLoS One. 2011;6:e17238. doi:https://doi.org/10.1371/journal.pone.0017238.
   Google Scholar
• Nyamundanda G, Poudel P, Patil Y, Sadanandam A. A novel statistical method to diagnose, quantify and correct batch effects in genomic studies. Sci Rep. 2017;7:10849. doi:https://doi.org/10.1038/s41598-017-11110-6.
   Google Scholar
• Liao B, Ning Z, Cheng K, Zhang X, Li L, Mayne J, Figeys D. iMetaLab 1.0: a web platform for metaproteomics data analysis. Bioinformatics. 2018;34:3954–3956. doi:https://doi.org/10.1093/bioinformatics/bty466.
   Google Scholar
• Chong J, Soufan O, Li C, Caraus I, Li S, Bourque G, Wishart DS, Xia J. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res. 2018;46:W486–W94. doi:https://doi.org/10.1093/nar/gky310.
   Google Scholar